You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER-2 Positive Breast Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)

Recruiting
  • Breast Cancer
  • +7 more
  • Dendritic Cell Vaccine (DC1)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 23, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jan 24, 2023

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Metastatic Breast Cancer, HER2 Positive Breast Carcinoma Trial in United States (Niraparib, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer
  • HER2 Positive Breast Carcinoma
  • Birmingham, Alabama
  • +6 more
Dec 13, 2022

HER2 Low Breast Carcinoma Trial (SHR-A1811 for injection)

Not yet recruiting
  • HER2 Low Breast Carcinoma
  • SHR-A1811 for injection
  • (no location specified)
Jun 12, 2023

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

HER2-positive Metastatic Breast Cancer, Locally Advanced HER2 Positive Breast Carcinoma Trial in Spain (Tucatinib, Trastuzumab,

Not yet recruiting
  • HER2-positive Metastatic Breast Cancer
  • Locally Advanced HER2 Positive Breast Carcinoma
  • Cádiz, Andalucía, Spain
  • +17 more
Jan 16, 2023

Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)

Recruiting
  • Breast Cancer Female
  • +7 more
  • DC1 Vaccine
  • WOKVAC Vaccine
  • Tampa, Florida
  • +6 more
Apr 4, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Best Practice
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 5, 2023

Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +18 more
  • Clinical Encounter
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jul 24, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Yuma, Arizona
  • +5 more
May 25, 2022

Advanced HER2 Negative Breast Carcinoma, HRD+Breast Cancer Trial in Tianjin (fluzoparib+chidamide, fluzoparib+camrelizumab)

Recruiting
  • Advanced HER2 Negative Breast Carcinoma
  • HRD+Breast Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Sep 27, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma Trial (other, procedure, behavioral)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Electronic Health Record Review
  • +6 more
  • (no location specified)
Oct 27, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +5 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jul 14, 2022

Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Washington, District of Columbia
  • +4 more
Jan 31, 2023

Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

Recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

    Terminated
    • Estrogen Receptor Positive
    • +16 more
    • Biopsy of Breast
    • +5 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Sep 22, 2022